German contribution to development and innovations in the management of acute myocardial infarction and cardiogenic shock.
Treatment of acute coronary syndromes has evolved over time leading to a significantly reduced mortality. Multiple major trials have been performed in Germany leading to new treatment strategies in acute coronary syndromes including cardiogenic shock. This review article will summarize major trials and their impact on guideline recommendations in acute myocardial infarction highlighting reperfusion strategies, antiplatelet regimens, prognosis assessment and also mechanical circulatory support in stable infarction patients and in cardiogenic shock.
['Feistritzer|Hans-Josef|HJ|', 'Desch|Steffen|S|', 'de Waha|Suzanne|S|', 'Jobs|Alexander|A|', 'Zeymer|Uwe|U|', 'Thiele|Holger|H|']
D019468:Disease Management D005858:Germany D006801:Humans D009203:Myocardial Infarction D011379:Prognosis D012770:Shock, Cardiogenic
Infarction Cardiogenic shock Acute coronary syndrome Antithrombotic treatment Stent